Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device
NCT ID: NCT02596789
Last Updated: 2017-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2012-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to investigate the impact of aging on cortical excitability (CE)
* to investigate the impact of "state dependency" on CE, using a cognitive task and an emotional one.
A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic response are recorded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation
NCT02168413
The Relationships Between Neural Correlates of Effort Perception and Physical Activity Engagement
NCT06691490
Effects of Peripheral Magnetic Stimulation on Cortical Excitability in Healthy Individuals
NCT07025759
Pain Assessment and Transcranial Magnetic Stimulation Tolerability in Patients With a Functional Neurological Disorder
NCT06149728
Cortical Plasticity After Motor Cortex Stimulation in Healthy Subject and Chronic Pain Patients
NCT02849834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
state dependency TMS
TMS performed at rest and during a cognitive/emotional task
TMS "Magpro®, Magventure Inc" device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TMS "Magpro®, Magventure Inc" device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-75
* signed informed consent
* normal physical examination
Exclusion Criteria
* contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac pacemaker, pregnancy, jet lag or severe insomnia the night before
* severe physical disease
* treatment with psychotropic drugs
* overt psychiatric disease
* alcohol consumption before the examination
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry BOUGEROL, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry & Neurology - University Hospital Grenoble
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00316-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.